Gilead Sciences reported $5.17B in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbvie ABBV:US $ 9517M 1089M
Acorda Therapeutics ACOR:US $ 16.57M 16.2M
ALKERMES ALKS:US 223.39M 47.4M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Amgen AMGN:US $ 4677M 451M
Biogen BIIB:US $ 1777.9M 295.8M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Bristol Myers Squibb BMY:US $ 9177M 452M
Coherus Biosciences CHRS:US $ 50.74M 10.52M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Gilead Sciences GILD:US $ 5166M 549M
Glaxosmithkline GSK:US $ 6135M 283M
GlaxoSmithKline GSK:LN 6.14B 283M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
Johnson & Johnson JNJ:US $ 15828M 1021M
Merk MRK:US $ 10567M 873M
Moderna Inc MRNA:US 5.05B 1.21B
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Novartis NOVN:VX 9.52B 3M
Pfizer PFE:US $ 15651M 1516M
Puma Biotechnology PBYI:US $ 34.89M 8.57M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Teva Pharmaceutical Industries TEVA:US $ 1802M 323M
United Therapeutics UTHR:US $ 436M 55.4M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M
YTE INCY:US $ 696.02M 128.26M